Latest news with #Emami
The Print
18-07-2025
- Business
- The Print
Emami tightens hold on pet care associate Cannis Lupus
According to a regulatory filing with stock exchanges on Thursday, Emami will convert existing inter-corporate loans of around Rs 8.23 crore into OCDs and infuse an additional Rs 4 crore through fresh subscription to these instruments. The Kolkata-headquartered company has executed an agreement to subscribe to Optionally Convertible Debentures (OCDs) issued by Cannis Lupus, which operates in the pet care segment under the brand 'Fur Ball Story'. Kolkata, Jul 17 (PTI) FMCG major Emami Ltd on Thursday said it will convert loans and make fresh investments in its associate company, Cannis Lupus Services, as part of its long-term growth strategy. The investment, the company said, aligns with its strategic focus on expanding into complementary wellness and lifestyle categories, though Cannis Lupus operates outside Emami's core FMCG business. Cannis Lupus, incorporated in 2019 and based in Gurugram, offers ayurvedic and herbal remedies for pets and is developing a portfolio of medicinal foods, supplements, and other pet care products. Its turnover stood at Rs 510 lakh in FY25, down from Rs 666 lakh in FY24. Emami has been gradually diversifying its portfolio in recent years through investments in wellness and healthcare adjacencies, including brands such as The Man Company, Brillare Science, and TruNativ. Shares of Emami closed at Rs 587.50 apiece on the NSE, up by 1.40 points or 0.24 per cent on Thursday. PTI BSM SBN SBN This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Economic Times
18-07-2025
- Business
- Economic Times
Newgen Software shares fall over 11% in two days after weak Q1 results
Shares of Newgen Software have dropped more than 11% over the past two sessions following the company's disappointing Q1FY26 earnings. On Friday, the stock fell nearly 6% to Rs 968 on BSE. ADVERTISEMENT Newgen Software reported a consolidated net profit of Rs 49.72 crore for the April–June quarter, marking a modest 4.5% year-on-year increase from Rs 47.57 crore. However, on a sequential basis, profit fell sharply by 54% from Rs 108 crore in Q4FY25. Revenue from operations grew just 2% YoY to Rs 321 crore but dropped over 25% compared to Rs 430 crore in the previous quarter. Also Read: Emami, Tube Investment among 10 mid-cap stocks analysts expect to gain up to 40% The company's operating performance also weakened. EBITDA declined 6% YoY to Rs 45 crore, while EBITDA margin narrowed to 14% from 15% a year ago. The decline was primarily attributed to higher employee benefit expenses and increased finance key markets, revenue from the India business showed a slight YoY increase but declined sharply from the March quarter. Revenue from Europe fell to Rs 103.4 crore from Rs 138.56 crore QoQ. ADVERTISEMENT APAC revenue remained flat YoY at Rs 49.9 crore but declined from Rs 69.2 crore in Q4FY25. Similarly, revenue from the US market was flat YoY but lower sequentially. Also Read: 9 undervalued mid-cap stocks with upside potential of up to 23% ADVERTISEMENT Newgen Software share price target According to Trendlyne, the average target price for Newgen Software is Rs 1,186, indicating a potential upside of nearly 22% from current levels. Of the four analysts tracking the stock, the consensus rating is 'Buy'. Also Read: SBI, Federal Bank among 11 banks that saw NPA improvement in Q4 (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
18-07-2025
- Business
- Time of India
Newgen Software shares fall over 11% in two days after weak Q1 results
Shares of Newgen Software have dropped more than 11% over the past two sessions following the company's disappointing Q1FY26 earnings. On Friday, the stock fell nearly 6% to Rs 968 on BSE. Newgen Software Q1 performance Explore courses from Top Institutes in Select a Course Category Cybersecurity Data Analytics Digital Marketing Leadership Design Thinking Operations Management Degree CXO Management healthcare Finance MCA Project Management Data Science MBA Data Science Artificial Intelligence Public Policy others Healthcare Product Management Others Technology Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details Newgen Software reported a consolidated net profit of Rs 49.72 crore for the April–June quarter, marking a modest 4.5% year-on-year increase from Rs 47.57 crore. However, on a sequential basis, profit fell sharply by 54% from Rs 108 crore in Q4FY25. Revenue from operations grew just 2% YoY to Rs 321 crore but dropped over 25% compared to Rs 430 crore in the previous quarter. Also Read: Emami, Tube Investment among 10 mid-cap stocks analysts expect to gain up to 40% The company's operating performance also weakened. EBITDA declined 6% YoY to Rs 45 crore, while EBITDA margin narrowed to 14% from 15% a year ago. The decline was primarily attributed to higher employee benefit expenses and increased finance costs. Among key markets, revenue from the India business showed a slight YoY increase but declined sharply from the March quarter. Revenue from Europe fell to Rs 103.4 crore from Rs 138.56 crore QoQ. APAC revenue remained flat YoY at Rs 49.9 crore but declined from Rs 69.2 crore in Q4FY25. Similarly, revenue from the US market was flat YoY but lower sequentially. Also Read: 9 undervalued mid-cap stocks with upside potential of up to 23% Newgen Software share price target According to Trendlyne, the average target price for Newgen Software is Rs 1,186, indicating a potential upside of nearly 22% from current levels. Of the four analysts tracking the stock, the consensus rating is 'Buy'. Also Read: SBI, Federal Bank among 11 banks that saw NPA improvement in Q4 ( Disclaimer : Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)
News18
17-07-2025
- Business
- News18
Emami tightens hold on pet care associate Cannis Lupus
Kolkata, Jul 17 (PTI) FMCG major Emami Ltd on Thursday said it will convert loans and make fresh investments in its associate company, Cannis Lupus Services, as part of its long-term growth strategy. The Kolkata-headquartered company has executed an agreement to subscribe to Optionally Convertible Debentures (OCDs) issued by Cannis Lupus, which operates in the pet care segment under the brand 'Fur Ball Story'. According to a regulatory filing with stock exchanges on Thursday, Emami will convert existing inter-corporate loans of around Rs 8.23 crore into OCDs and infuse an additional Rs 4 crore through fresh subscription to these instruments. The investment, the company said, aligns with its strategic focus on expanding into complementary wellness and lifestyle categories, though Cannis Lupus operates outside Emami's core FMCG business. Cannis Lupus, incorporated in 2019 and based in Gurugram, offers ayurvedic and herbal remedies for pets and is developing a portfolio of medicinal foods, supplements, and other pet care products. Its turnover stood at Rs 510 lakh in FY25, down from Rs 666 lakh in FY24. Emami has been gradually diversifying its portfolio in recent years through investments in wellness and healthcare adjacencies, including brands such as The Man Company, Brillare Science, and TruNativ. Shares of Emami closed at Rs 587.50 apiece on the NSE, up by 1.40 points or 0.24 per cent on Thursday. PTI BSM SBN SBN (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: July 17, 2025, 20:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Business Standard
09-07-2025
- Business
- Business Standard
Benchmarks trade with small gains; FMCG shares in demand
The frontline indices continued to trade with minor gains in the mid-morning trade amid a lack of clear directional cues. The Nifty traded above the 25,500 level. FMCG shares advanced after declining in the past trading session. At 11:30 IST, the barometer index, the S&P BSE Sensex, added 28.27 points or 0.03% to 83,740.78. The Nifty 50 index rose 20.45 points or 0.08% to 25,543.15. In the broader market, the S&P BSE Mid-Cap index rose 0.07% and the S&P BSE Small-Cap index added 0.53%. The market breadth was positive. On the BSE, 2,186 shares rose and 1,535 shares fell. A total of 168 shares were unchanged. IPO Update: The initial public offer (IPO) of Travel Food Services received bids for 51,37,353 shares as against 1,34,12,842 shares on offer, according to stock exchange data at 11:30 IST on Wednesday (9 July 2025). The issue was subscribed 0.38 times. The issue opened for bidding on Monday (7 July 2025) and it will close on Wednesday (9 July 2025). The price band of the IPO is fixed between Rs 1,045 and 1,100 per share. An investor can bid for a minimum of 13 equity shares and in multiples thereof. Buzzing Index: The Nifty FMCG index rose 0.60% to 55,836.05. The index declined 0.27% in the past trading session. Emami (up 2.51%), Godrej Consumer Products (up 1.95%), Varun Beverages (up 1.94%), Dabur India (up 1.5%), Hindustan Unilever (up 0.84%), Radico Khaitan (up 0.82%), Nestle India (up 0.24%), Britannia Industries (up 0.15%), ITC (up 0.14%) and United Spirits (up 0.12%) advanced. On the other hand, United Breweries (down 0.74%), Marico (down 0.61%) and Colgate-Palmolive (India) (down 0.27%) edged lower. Stocks in Spotlight: Signatureglobal (India) rose 0.69%. The company reported a 63% quarter-on-quarter (QoQ) increase in pre-sales to Rs 2,640 crore in Q1 FY26, compared to Rs 1,620 crore in Q4 FY25. R Systems International advanced 0.56%. The company announced that its board had approved a proposal to raise funds through issue of debt securities worth Rs 275 crore. Global Markets: Asian markets traded mixed after US President Donald Trump ruled out any extension to the looming August 1 tariff deadline. On Tuesday, he also announced a steep 50% duty on copper imports and signaled that more sector-specific tariffs could follow soon. In a bold move, Trump threatened to slap tariffs of up to 200% on pharmaceutical exports to the US. However, he added a grace period of "about a year, year and a half" before the measure kicks in. Meanwhile, fresh economic data from China painted a mixed picture. The country's producer price index tumbled 3.6% in June from a year earlier, the sharpest drop in nearly two years. On the flip side, the consumer price index inched up just 0.1% year-on-year. Back in the US, Wall Street remained jittery over escalating trade tensions. The Dow fell 0.37%, the S&P 500 slipped 0.07%, and the NASDAQ managed a slim gain of 0.03%. All eyes now turn to the Federal Reserve, with the minutes from its June policy meeting set to be released later today. Investors will be scanning the details for clues on the Fed's next move on interest rates.
